BARTOLETTI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 2.365
AS - Asia 1.037
EU - Europa 623
SA - Sud America 147
Continente sconosciuto - Info sul continente non disponibili 119
AF - Africa 29
OC - Oceania 2
Totale 4.322
Nazione #
US - Stati Uniti d'America 2.310
SG - Singapore 480
CN - Cina 202
IT - Italia 135
BR - Brasile 114
VN - Vietnam 95
HK - Hong Kong 87
DE - Germania 84
RU - Federazione Russa 78
BD - Bangladesh 57
GB - Regno Unito 49
FR - Francia 48
UA - Ucraina 45
FI - Finlandia 41
IN - India 34
IE - Irlanda 30
CA - Canada 29
SE - Svezia 29
ES - Italia 17
BE - Belgio 16
PL - Polonia 14
MX - Messico 13
TR - Turchia 13
EG - Egitto 12
JP - Giappone 10
NL - Olanda 10
ID - Indonesia 9
AR - Argentina 8
EC - Ecuador 8
KR - Corea 8
VE - Venezuela 8
ZA - Sudafrica 6
AZ - Azerbaigian 5
CO - Colombia 5
CZ - Repubblica Ceca 5
IQ - Iraq 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
LT - Lituania 4
PK - Pakistan 4
RO - Romania 3
BO - Bolivia 2
CL - Cile 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
IR - Iran 2
KE - Kenya 2
NG - Nigeria 2
NP - Nepal 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GP - Guadalupe 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
MA - Marocco 1
ME - Montenegro 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
QA - Qatar 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 4.204
Città #
Singapore 248
Ashburn 243
Chandler 193
San Jose 161
Fairfield 132
Woodbridge 110
Council Bluffs 98
Beijing 96
Ann Arbor 91
Hong Kong 85
Houston 67
Seattle 63
New York 54
Wilmington 51
Boardman 49
Cambridge 44
Los Angeles 44
Lauterbourg 33
Ho Chi Minh City 30
Munich 30
Santa Clara 29
Dublin 27
Princeton 27
Dearborn 23
Helsinki 23
Dong Ket 19
Dallas 18
Jacksonville 18
Frankfurt am Main 16
Hanoi 16
Redmond 16
Brussels 15
Buffalo 15
São Paulo 15
Chicago 14
Phoenix 14
London 13
Montreal 13
Warsaw 13
Redondo Beach 12
Nuremberg 11
Turku 11
Poplar 10
The Dalles 10
Chennai 9
Izmir 9
Martignacco 9
Ogden 9
Orem 9
San Diego 9
Stockholm 9
Tokyo 9
Brooklyn 8
Denver 8
Hefei 8
Milan 8
Des Moines 7
Belo Horizonte 6
Boston 6
City of London 6
Hyderabad 6
Newark 6
Rome 6
San Francisco 6
Seoul 6
Washington 6
Augusta 5
Düsseldorf 5
Haiphong 5
Johannesburg 5
Naples 5
Shanghai 5
Toronto 5
Andover 4
Baku 4
Brno 4
Charlotte 4
Falls Church 4
Hải Dương 4
Leawood 4
Manchester 4
Miami 4
Philadelphia 4
San Antonio 4
San Mateo 4
Udine 4
Zoppola 4
Al Qahirah al Jadidah 3
Athens 3
Baghdad 3
Belluno 3
Bắc Ninh 3
Caracas 3
Genoa 3
Guayaquil 3
Jinan 3
Madrid 3
Majano 3
Medina 3
Mexico City 3
Totale 2.615
Nome #
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 225
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 206
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 197
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 195
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 186
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 170
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 158
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 156
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer 154
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 148
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study 148
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 142
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 141
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 134
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 127
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 121
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 120
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer 115
Bevacizumab or PARP-Inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: A network meta-analysis 114
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World 105
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: The virtual experience of the MITO cooperative group 96
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis 93
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 92
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 90
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva 88
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: A retrospective MITO group study 86
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 82
Managing COVID-19 in the oncology clinic and avoiding the distraction effect 82
An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer 79
The Role of Obesity in Early and Long-Term Outcomes after Surgical Excision of Lung Oligometastases from Colorectal Cancer 78
AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization 75
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors 71
Evaluating the role of secondary surgery and PARP inhibition in platinum-sensitive ovarian cancer relapse 64
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)2NS) for Ovarian Cancer Therapy 62
Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer 54
Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial Cancer 35
Late peritoneal carcinomatosis from cutaneous melanoma mimicking ovarian cancer 33
Totale 4.322
Categoria #
all - tutte 17.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.921


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022219 0 0 6 7 9 7 16 8 1 38 95 32
2022/2023381 32 42 9 50 42 83 1 37 61 3 11 10
2023/2024187 19 16 15 9 31 44 0 10 12 9 0 22
2024/2025723 31 41 28 42 46 31 66 46 76 69 93 154
2025/20261.711 201 123 91 143 261 143 182 69 153 122 153 70
2026/2027225 34 157 34 0 0 0 0 0 0 0 0 0
Totale 4.322